肾下腹主动脉瘤腔内修复术后II型内漏的发生率、自然病程与结局:基于ENGAGE登记数据
基于ENGAGE前瞻性真实世界登记数据,5年随访中孤立性II型内漏发生率为15.6%,多数无需二次干预,早期孤立性II型内漏1年内不影响健康状况;但10%的II型内漏患者后续出现迟发I型内漏,二次干预率高达67.5%。
要点
- ENGAGE登记5年随访孤立性II型内漏发生率为15.6%,多数无需二次干预。
- II型内漏患者动脉瘤增长和二次腔内干预发生率更高(5年15.4% vs 7.5%,P < .001)。
- 10%的II型内漏患者出现迟发I型内漏,5年二次干预率67.5%。
核心结论
- ENGAGE登记中孤立性II型内漏5年随访发生率为15.6%,多数无需二次干预,早期孤立性II型内漏1年内不影响健康状况。
- 少数II型内漏患者后续出现I型内漏,导致高二次干预率和显著动脉瘤相关并发症风险。
研究设计与样本
- 前瞻性真实世界多中心登记研究(ENGAGE),分析孤立性II型内漏患者及II型内漏后出现I型内漏的患者。
- 比较早期II型内漏与无内漏患者的健康状况,并尝试识别II型内漏后出现I型内漏的危险因素。
主要发现
- 5年随访共识别197例(15.6%)孤立性II型内漏,其中37.1%(n=73)在30天内检出,37.1%(n=73)在1年内检出,25.8%(n=51)在1年后检出。
- II型内漏患者动脉瘤增长发生率更高,5年二次腔内干预率为15.4% vs 7.5%(P < .001)。
- 孤立性II型内漏组总生存率高于无内漏组(5年77.2% vs 67.0%,P = .010)。
- 早期II型内漏与无任何内漏患者在1年随访时健康状况评分无差异。
临床怎么用
- 孤立性II型内漏多数可保守观察,无需常规二次干预。
- 对II型内漏患者需警惕迟发I型内漏,应规律影像随访以及时发现并处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to report the incidence, natural history, and outcome of type II endoleaks in the largest prospective real-world cohort to date. METHODS: Patients were extracted from the prospective Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE). Two groups were analyzed: first, patients with an isolated type II endoleak; and second, patients with a type II endoleak who later presented with a type I endoleak. A health status analysis between patients with an early type II endoleak and patients with no endoleak was performed. Second, an attempt was made to identify risk factors in patients with a type II endoleak who later presented with a type I endoleak. RESULTS: Through 5 years of follow-up, a total of 197 (15.6%) patients with isolated type II endoleaks were identified. Most were detected within the first 30 days (n = 73 [37.1%]) and through the first year (n = 73 [37.1%]), with the remainder being detected after 1 year of follow-up (n = 51 [25.8%]). Patients with a type II endoleak had a higher incidence of aneurysm growth and more secondary endovascular procedures (15.4% vs 7.5% at 5 years; P < .001). Overall survival was higher in the isolated type II endoleak group compared with patients with no endoleak (77.2% vs 67.0% at 5 years; P = .010). Twenty-two patients (10%) with a type II endoleak were diagnosed with a late type I endoleak (type IA, n = 10; type IB, n = 12), with a secondary intervention rate of 67.5% through 5 years. There was no difference in health status scores between patients with an early type II endoleak and patients without any type of endoleak at 1-year follow-up. CONCLUSIONS: In the ENGAGE registry, isolated type II endoleaks are present in 15.6% of patients during follow-up. The majority do not require secondary intervention, and an early isolated type II endoleak does not have an impact on health status through 1 year. However, a small group of patients with a type II endoleak will present with a type I endoleak, resulting in a high secondary intervention rate and significant risk of aneurysm-related complications.
引用
- Dijkstra ML, Zeebregts CJ, Verhagen HJM, et al. Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data. J Vasc Surg. 2019. PMID: 31443976. doi:10.1016/j.jvs.2019.04.486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。